Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the […]

Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the

Schering’s Dr. Feelbetter? Fred Hassan is out to revive the drugmaker. It’s a big job

Schering’s Dr. Feelbetter? Fred Hassan is out to revive the drugmaker. It’s a big job

FDA approves first nasal mist flu vaccine Most people who avoid flu shots because they fear needles will not have

Microsoft loses No. 2 ranking in market value to drug maker Microsoft has lost its status as the world’s second-largest

Report Says More Farmers Don’t Follow Biotech Rules A new study, drawn from government data, shows that more farmers are

Report Says More Farmers Don’t Follow Biotech Rules A new study, drawn from government data, shows that more farmers are

More regulations for biotech products aren’t necessary, FDA says Genetically engineered foods from crops that have already been reviewed and

More regulations for biotech products aren’t necessary, FDA says Genetically engineered foods from crops that have already been reviewed and